Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001834445-20-000001
Filing Date
2020-12-03
Accepted
2020-12-03 10:14:53
Documents
1
Effectiveness Date
2020-12-03
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7194
  Complete submission text file 0001834445-20-000001.txt   8321
Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 0 20 7534 1508
Abingworth Clinical Co-Development Fund 2 LP (Filer) CIK: 0001834445 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-382087 | Film No.: 201365956